Investing.com -- Upcoming first-quarter earnings from software companies are unlikely to be the catalyst for a broad re-rating of the software-as-a-service sector, Morgan Stanley said, even if results come in ahead of expectations.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
高シグナルの見出しのみ — マクロイベント、決算、M&A、規制。リスト記事とアナリストのクリックベイトはデフォルトでフィルタ。1時間ごとに更新。
Investing.com -- Upcoming first-quarter earnings from software companies are unlikely to be the catalyst for a broad re-rating of the software-as-a-service sector, Morgan Stanley said, even if results come in ahead of expectations.
Lowe's stock was dropping after it beat earnings expectations but warned of a challenging housing market.
Nvidia reports after the market close on May 20. Morgan Stanley's analyst Joseph Moore published his preview note on May 18. And the number at the center of his argument is one that the rest of Wall Street is, in his view, significantly underestimating. That number is $1 trillion. And whether you ...
There's a version of Cisco (CSCO) that Wall Street wrote off years ago — a legacy networking giant stuck in the slow lane while flashier AI names grabbed all the attention. That story is getting harder to tell lately. The 41-year-old multinational technology conglomerate headquartered in California ...
Morgan Stanley (MS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
There's a version of Walmart most people still picture. Fluorescent lights, crowded aisles, maybe a cart with a wobbly wheel. That version still exists. But the company Wall Street is paying 43 times forward earnings for? That's a different beast entirely.As of 2026, Walmart is a 63-year-old ...
Omda's fair value price target of NOK 57.0 is unchanged, providing a steady reference point while assumptions around discount rates and growth are fine tuned. Recent analyst research shows price targets moving both higher and lower as models are refreshed after Q4 results, updated revenue outlooks and shifting views on growth drivers such as GLP-1 related and multi condition programs. As you read on, you will see how this evolving narrative can shape the way you track Omda's equity story over...
Healthcare stocks have had a rough stretch. Rising medical costs, Medicaid pressure, and persistent skepticism about managed care margins have kept investors on edge all year. Walking into a CVS Health earnings report in that environment felt like bracing for bad news. The bad news, however, didn't ...
IonQ (IONQ) has become one of the market’s hottest quantum computing stocks, with shares rising roughly 70% over the past year as investors bet the company can turn early quantum leadership into a scalable commercial platform. Now, Morgan Stanley is signaling that the story may be entering a new ...
Gilead Sciences (GILD) raised Yeztugo guidance for 2026 to $1 billion from $800 million, which is "g
You know that feeling when you've been backing a friend's idea for months, and then suddenly the whole room starts paying attention? That's roughly where Morgan Stanley finds itself with Advanced Micro Devices (AMD). For the better part of six months, the firm had been quietly bullish on AMD's ...
IonQ (IONQ) continues to beat quarterly revenue guidance, with momentum remaining strong and the com